Effects and clinical significance of pentoxifylline on the oxidative stress of rats with diabetic nephropathy

[1]  Ling Xia,et al.  Inhibition of Src Kinase Blocks High Glucose–Induced EGFR Transactivation and Collagen Synthesis in Mesangial Cells and Prevents Diabetic Nephropathy in Mice , 2013, Diabetes.

[2]  M. Islam.  Animal Models of Diabetic Neuropathy: Progress Since 1960s , 2013, Journal of diabetes research.

[3]  W. Cui,et al.  Advances in Murine Models of Diabetic Nephropathy , 2013, Journal of diabetes research.

[4]  A. Mima.  Inflammation and Oxidative Stress in Diabetic Nephropathy: New Insights on Its Inhibition as New Therapeutic Targets , 2013, Journal of diabetes research.

[5]  Brian M. Shepler,et al.  Potential new treatments for diabetic kidney disease. , 2013, The Medical clinics of North America.

[6]  M. Tavafi.  Diabetic nephropathy and antioxidants. , 2013, Journal of nephropathology.

[7]  S. Hazen,et al.  Pentoxifylline decreases oxidized lipid products in nonalcoholic steatohepatitis: New evidence on the potential therapeutic mechanism , 2012, Hepatology.

[8]  M. Sánchez-Niño,et al.  2012 update on diabetic kidney disease: the expanding spectrum, novel pathogenic insights and recent clinical trials. , 2012, Minerva medica.

[9]  Harold I Feldman,et al.  Estimating glomerular filtration rate from serum creatinine and cystatin C. , 2012, The New England journal of medicine.

[10]  S. Han,et al.  Phosphodiesterase Inhibitor Improves Renal Tubulointerstitial Hypoxia of the Diabetic Rat Kidney , 2012, The Korean journal of internal medicine.

[11]  L. Joosten,et al.  Oxidative and nitrosative stress in acute pancreatitis. Modulation by pentoxifylline and oxypurinol. , 2012, Biochemical pharmacology.

[12]  M. Biyani,et al.  Targeted therapies in diabetic nephropathy: an update. , 2011, Journal of nephrology.

[13]  J. Navarro-González,et al.  Pentoxifylline for renoprotection in diabetic nephropathy: the PREDIAN study. Rationale and basal results. , 2011, Journal of diabetes and its complications.

[14]  R. Stanton.  Oxidative Stress and Diabetic Kidney Disease , 2011, Current diabetes reports.

[15]  X. H. Lu,et al.  Protective Effects of Luteolin on Diabetic Nephropathy in STZ-Induced Diabetic Rats , 2011, Evidence-based complementary and alternative medicine : eCAM.

[16]  M. Abdollahi,et al.  A review of the potential benefits of pentoxifylline in diabetic and non-diabetic proteinuria. , 2011, Journal of pharmacy & pharmaceutical sciences : a publication of the Canadian Society for Pharmaceutical Sciences, Societe canadienne des sciences pharmaceutiques.

[17]  G. Striker,et al.  Cardiovascular , Pulmonary and Renal Pathology Induction of Diabetes in Aged C 57 B 6 Mice Results in Severe Nephropathy An Association with Oxidative Stress , Endoplasmic Reticulum Stress , and Inflammation , 2010 .

[18]  D. Cha,et al.  Prolonged Administration Enhances the Renoprotective Effect of Pentoxifylline via Anti-Inflammatory Activity in Streptozotocin-Induced Diabetic Nephropathy , 2010, Inflammation.

[19]  L. Markó,et al.  Effects of pentoxifylline and pentosan polysulphate combination therapy on diabetic neuropathy in type 2 diabetes mellitus , 2009, Acta Diabetologica.

[20]  S. Doucette,et al.  The effect of pentoxifylline on proteinuria in diabetic kidney disease: a meta-analysis. , 2008, American journal of kidney diseases : the official journal of the National Kidney Foundation.

[21]  Yung-Ming Chen,et al.  Pentoxifylline attenuated the renal disease progression in rats with remnant kidney. , 2002, Journal of the American Society of Nephrology : JASN.